SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14687899
Source:
http://linkedlifedata.com/resource/pubmed/id/14687899
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0023823
,
umls-concept:C0086045
,
umls-concept:C0087111
pubmed:issue
1-2
pubmed:dateCreated
2003-12-22
pubmed:abstractText
Drug therapy is considered essential to the clinical prevention of atherosclerotic lesions in patients with diabetes mellitus (DM).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/1302422
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B
,
http://linkedlifedata.com/resource/pubmed/chemical/Bezafibrate
,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, LDL
,
http://linkedlifedata.com/resource/pubmed/chemical/Malondialdehyde
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0009-8981
pubmed:author
pubmed-author:ItoSachikoS
,
pubmed-author:KannoTakashiT
,
pubmed-author:KoboriKiichiroK
,
pubmed-author:KondoAkiraA
,
pubmed-author:KotaniKazuoK
,
pubmed-author:MaekawaMasatoM
,
pubmed-author:ManabeMitsuhisaM
,
pubmed-author:MoritaHiroshiH
,
pubmed-author:NakamuraHirotoshiH
,
pubmed-author:SaitoKazunoriK
pubmed:issnType
Print
pubmed:volume
339
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
97-103
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14687899-Adult
,
pubmed-meshheading:14687899-Aging
,
pubmed-meshheading:14687899-Apolipoproteins B
,
pubmed-meshheading:14687899-Arteriosclerosis
,
pubmed-meshheading:14687899-Bezafibrate
,
pubmed-meshheading:14687899-Diabetes Complications
,
pubmed-meshheading:14687899-Diabetes Mellitus
,
pubmed-meshheading:14687899-Enzyme-Linked Immunosorbent Assay
,
pubmed-meshheading:14687899-Female
,
pubmed-meshheading:14687899-Humans
,
pubmed-meshheading:14687899-Lipoproteins, LDL
,
pubmed-meshheading:14687899-Male
,
pubmed-meshheading:14687899-Malondialdehyde
,
pubmed-meshheading:14687899-Middle Aged
,
pubmed-meshheading:14687899-Sex Characteristics
pubmed:year
2004
pubmed:articleTitle
Influence of fibrate treatment on malondialdehyde-modified LDL concentration.
pubmed:affiliation
Diagnostics Research Laboratories, Daiichi Pure Chemicals Co., 3-1, Kôyodai 3-Chome, Ryugasaki, Ibaraki 301-0852, Japan.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't